Valuation: Ha Tay Pharmaceutical

Market Cap 5,326B 203M 176M 163M 151M 284M 19.34B 289M 1.93B 758M 9.61B 761M 744M 32.31B P/E 2024
109x
P/E 2025 109x
Enterprise Value 5,424B 206M 179M 166M 154M 289M 19.7B 294M 1.97B 772M 9.79B 775M 758M 32.91B EV / Sales 2024
3.89x
EV / Sales 2025 2.68x
Free-Float
25%
Yield 2024 *
-
Yield 2025 -
1 day+0.51%
1 week-0.84%
Current month-9.54%
1 month-10.91%
3 months-17.18%
6 months-14.91%
Current year-16.00%
1 week 55,500
Extreme 55500
63,000
1 month 55,500
Extreme 55500
66,000
Current year 55,500
Extreme 55500
75,800
1 year 55,500
Extreme 55500
86,800
3 years 17,090.91
Extreme 17090.9091
100,818.18
5 years 11,980.52
Extreme 11980.5195
100,818.18
10 years 4,801.26
Extreme 4801.2593
100,818.18
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2016
Corporate Officer/Principal - 01/03/2016
Corporate Officer/Principal 49 04/02/2015
Director TitleAgeSince
Chairman 75 01/01/2016
Director/Board Member 53 -
Director/Board Member 62 01/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.51%-0.84%-23.91%+131.00% 203M
-4.55%-2.61%+51.95%+151.91% 1,030B
-3.66%-1.33%+52.95%+46.62% 617B
-2.24%+0.19%+35.97%+70.64% 455B
-2.29%+1.12%+36.13%+31.18% 350B
-2.28%-0.69%+33.42%+40.48% 299B
-3.15%+0.25%+10.63%+15.03% 265B
-2.12%+3.31%+1.82%-37.38% 225B
0.00%+4.34%+28.63%+64.00% 209B
-1.09%+0.32%+14.40%+70.80% 163B
Average -1.60%+4.10%+24.20%+58.43% 361.29B
Weighted average by Cap. -1.63%+4.87%+37.84%+72.20%

Financials

2024 2025
Net sales 2,086B 79.38M 68.95M 64.03M 59.05M 111M 7.58B 113M 758M 297M 3.76B 298M 292M 12.66B 2,402B 91.39M 79.38M 73.71M 67.98M 128M 8.72B 130M 873M 342M 4.33B 343M 336M 14.57B
Net income 71.77B 2.73M 2.37M 2.2M 2.03M 3.83M 261M 3.9M 26.08M 10.21M 129M 10.25M 10.03M 435M 53.66B 2.04M 1.77M 1.65M 1.52M 2.86M 195M 2.91M 19.49M 7.63M 96.79M 7.67M 7.5M 326M
Net Debt 290B 11.03M 9.58M 8.9M 8.21M 15.46M 1.05B 15.74M 105M 41.24M 523M 41.42M 40.51M 1.76B 98.73B 3.76M 3.26M 3.03M 2.79M 5.26M 359M 5.36M 35.87M 14.04M 178M 14.11M 13.8M 599M
Logo Ha Tay Pharmaceutical
Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The Company announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.
Employees
586
Date Price Change Volume
30/07/26 ₫58,800.00 +0.51% 2,200
29/07/26 ₫58,500.00 +0.17% 6,236
28/07/26 ₫58,400.00 -2.50% 18,000
27/07/26 ₫59,900.00 -0.66% 27,300
24/07/26 ₫60,300.00 +1.69% 11,352